JointHealth™ express September 30, 2010
Ankylosing Spondylitis Research Study
Physicians at The Arthritis Research Centre of Canada are seeking volunteers who have been diagnosed with Ankylosing Spondylitis (AS) to participate in a clinical research study involving an investigational study drug not yet approved by Health Canada.
Volunteers with AS who in the past have not responded or who have not tolerated standard anti-inflammatory medications, who meet criteria for entry into the study, and who consent to participation, would be randomly assigned to receive either active treatment (with an injectable study drug) or placebo (an injectable inactive substance). The chance of receiving placebo is 1 in 6. Participation in the study would involve 8 visits to the Arthritis Research Centre over 12 weeks with a possible extension study after 12 weeks.
If you are interested in learning more about this study and what participation would involve, please contact the Study Coordinators:
Please discuss your participation in this or any research study with your primary physician.
What is a clinical trial? To find out, click here. Or, you may find the January 2009 JointHealth™ monthly useful – it discusses the importance of consumer participation in clinical studies and provides a good description of what they are.
Ankylosing Spondylitis Research Study
Physicians at The Arthritis Research Centre of Canada are seeking volunteers who have been diagnosed with Ankylosing Spondylitis (AS) to participate in a clinical research study involving an investigational study drug not yet approved by Health Canada.
Volunteers with AS who in the past have not responded or who have not tolerated standard anti-inflammatory medications, who meet criteria for entry into the study, and who consent to participation, would be randomly assigned to receive either active treatment (with an injectable study drug) or placebo (an injectable inactive substance). The chance of receiving placebo is 1 in 6. Participation in the study would involve 8 visits to the Arthritis Research Centre over 12 weeks with a possible extension study after 12 weeks.
If you are interested in learning more about this study and what participation would involve, please contact the Study Coordinators:
|
Nancy Ellis RN 604.871.4573 nellis@arthritisresearch.ca |
Patricia Patrick RN 604.871.4531 ppatrick@arthritisresearch.ca |
Please discuss your participation in this or any research study with your primary physician.
What is a clinical trial? To find out, click here. Or, you may find the January 2009 JointHealth™ monthly useful – it discusses the importance of consumer participation in clinical studies and provides a good description of what they are.
Arthritis Consumer Experts
ACE thanks Arthritis Research Canada (ARC) for its scientific review of ACE and JointHealth™ information and education programs.